Sfoglia per RIVISTA
GYNECOLOGIC ONCOLOGY
Collezione AO Ordine Mauriziano

  

Items : 17

Impact of different follow-up regimens on health-related quality of life and costs in endometrial cancer patients: Results from the TOTEM randomized trial. in Gynecologic oncology / Gynecol Oncol. 2024 May;184:150-159. doi: 10.1016/j.ygyno.2024.01.050. Epub 2024 Feb 3.

2024
AOU Città della Salute di Torino
ASL Città di Torino
AO Ordine Mauriziano

Zola P; Laudani ME; Pace L; Pagano E; Fuso L; Piovano E; Di Cuonzo D; Evangelista A; Ciccone G; Ferrero A; Mosconi P; Rosato R;

Long-term follow-up of efficacy and safety of selinexor maintenance treatment in patients with TP53wt advanced or recurrent endometrial cancer: A subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study. in Gynecologic oncology / Gynecol Oncol. 2024 Jun;185:202-211. doi: 10.1016/j.ygyno.2024.05.016. Epub 2024 Jun 3.

2024
AO Ordine Mauriziano

Vergote I; Kalyanapu P; Walker CJ; Schochter F; Li K; Buscema J; Fariñas-Madrid L; Scambia G; Romero I; Berek JS; Makker V; Perez-Fidalgo JA; Pisano C; Chon HS; Martínez-Garcia J; Bedna?íková M; Wimberger P; Spitz DL; Henry S; De Giorgi U; Alía EMG; Miller DS; Perri T; Oza AM; Richardson DL; Reginá?ová K; Sehouli J; Van Gorp T; Valabrega G; et alii...

Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial. in Gynecologic oncology / Gynecol Oncol. 2024 Aug;187:128-138. doi: 10.1016/j.ygyno.2024.03.009. Epub 2024 Jun 3.

2024
AO Ordine Mauriziano

Sánchez AB; McCormick C; Baurain JF; González-Martín A; York W; Gupta D; Monk BJ; Valabrega G; Pothuri B; Levy T; Heitz F; Knudsen AØ; de La Motte Rouge T; Moore RG; Hietanen S; O'Cearbhaill RE; Tinker AV; Denys H; Graybill WS; Oaknin A;

Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial. in Gynecologic oncology / Gynecol Oncol. 2023 May;172:72-77. doi: 10.1016/j.ygyno.2023.03.011. Epub 2023 Mar 23.

2023
AO Ordine Mauriziano

Pignata S; Scambia G; Lorusso D; Perrone F; Fagotti A; Raspagliesi F; Ventriglia J; Cecere SC; Valabrega G; Priolo D; Salutari V; Marchetti C; Pisano C; Loizzi V; Cormio G; Tuninetti V; Califano D; Turinetto M; Arenare L; Bartoletti M; Musacchio L;

Maintenance olaparib in patients with platinum-sensitive relapsed ovarian cancer: Outcomes by somatic and germline BRCA and other homologous recombination repair gene mutation status in the ORZORA trial. in Gynecologic oncology / Gynecol Oncol. 2023 May;172:121-129. doi: 10.1016/j.ygyno.2023.03.019. Epub 2023 Apr 6.

2023
AO Ordine Mauriziano

Pignata S; Oza A; Hall G; Pardo B; Madry R; Cibula D; Klat J; Montes A; Glasspool R; Colombo N; Pete I; Herrero Ibáñez A; Marín MR; Ilieva R; Timcheva C; Di Maio M; Blakeley C; Taylor R; Barnicle A; Clamp A;

Randomized phase II BGOG/ENGOT-cx1 study of paclitaxel-carboplatin with or without nintedanib in first-line recurrent or advanced cervical cancer. in Gynecologic oncology / Gynecol Oncol. 2023 Jul;174:80-88. doi: 10.1016/j.ygyno.2023.04.028. Epub 2023 May 9.

2023
AO Ordine Mauriziano

Vergote I; Van Nieuwenhuysen E; Casado A; Laenen A; Lorusso D; Braicu EI; Guerra-Alia E; Zola P; Wimberger P; Debruyne PR; Falcó E; Ferrero A; Muallem MZ; Kerger J; García-Martinez E; Pignata S; Sehouli J; Van Gorp T; Gennigens C; Rubio MJ;

Consensus statements and treatment algorithm to guide clinicians in the selection of maintenance therapy for patients with newly diagnosed, advanced ovarian carcinoma: Results of a Delphi study. in Gynecologic oncology / Gynecol Oncol. 2023 Aug;175:182-189. doi: 10.1016/j.ygyno.2023.05.065. Epub 2023 Jun 22.

2023
ASL Biella
AO Ordine Mauriziano

Pignata S; Tomao F; Valabrega G; Zavallone L; Tasca G; Salutari V; Scandurra G; Savarese A; Sambataro D; Petrella MC; Ricciardi GRR; Ronzino G; Naglieri E; Mangili G; Mammoliti S; Lissoni A; De Angelis C; Legge F; Cormio G; Cecere SC; Ceccherini R; Landoni F; Lorusso D; Sabbatini R; Artioli G; Berardi R; Colombo N; Gadducci A;

Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer. in Gynecologic oncology / Gynecol Oncol. 2022 Sep;166(3):561-566. doi: 10.1016/j.ygyno.2022.07.022. Epub 2022 Jul 29.

2022
AO Cuneo
AO Ordine Mauriziano
AOU Novara

Raspagliesi F; Panici PB; Muzii L; Ghezzi F; Landoni F; Scambia G; Donato VD; Bogani G;

Hypersensitivity to platinum salts according to BRCA status in ovarian cancer: A retrospective analysis of clinical outcomes and systematic review of literature. in Gynecologic oncology / Gynecol Oncol. 2021 Jul;162(1):80-87. doi: 10.1016/j.ygyno.2021.04.018. Epub 2021 Apr 22.

2021
AO Ordine Mauriziano
ASL VCO
ASL Biella
AOU Città della Salute di Torino

Di Maio M; Pasini B; Valabrega G; Aglietta M; Gemmiti S; Turinetto M; Zavallone L; Mittica G; Mangiacotti S; Villa M; Tuninetti V; Ferrero A; Ghisoni E; Farolfi A; Borella F; Cosma S; Giannone G; Scotto G; De Giorgi U; Katsaros D;

Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer. in Gynecologic oncology / Gynecol Oncol. 2019 Sep;154(3):480-486. doi: 10.1016/j.ygyno.2019.07.006. Epub 2019 Jul 16.

2019
AO Ordine Mauriziano

Zanfagnin V; Huang Y; Mc Gree ME; Weaver AL; Casarin J; Multinu F; Cappuccio S; Ferrero A; Mariani A; Glaser GE;

Laparoscopic vs. open treatment of endometrial cancer in the elderly and very elderly: An age-stratified multicenter study on 1606 women. in Gynecologic oncology / Gynecol Oncol. 2016 May;141(2):211-217. doi: 10.1016/j.ygyno.2016.02.029. Epub 2016 Feb 28.

2016
AO Ordine Mauriziano

Uccella S; Bonzini M; Palomba S; Fanfani F; Malzoni M; Ceccaroni M; Seracchioli R; Ferrero A; Berretta R; Vizza E; Sturla D; Roviglione G; Monterossi G; Casadio P; Volpi E; Mautone D; Corrado G; Bruni F; Scambia G; Ghezzi F;

LIN-28B/let-7a/IGF-II axis molecular subtypes are associated with epithelial ovarian cancer prognosis. in Gynecologic oncology / Gynecol Oncol. 2016 Apr;141(1):121-7. doi: 10.1016/j.ygyno.2015.12.035. Epub 2016 Jan 2.

2016
AO Ordine Mauriziano
AOU Città della Salute di Torino

Lu L; Katsaros D; Canuto EM; Biglia N; Risch HA; Yu H;

TOP2A gene copy gain predicts response of epithelial ovarian cancers to pegylated liposomal doxorubicin: TOP2A as marker of response to PLD in ovarian cancer. in Gynecologic oncology / Gynecol Oncol. 2015 Sep;138(3):627-33. doi: 10.1016/j.ygyno.2015.06.025. Epub 2015 Jun 20.

2015
AO Ordine Mauriziano

Erriquez J; Becco P; Olivero M; Ponzone R; Maggiorotto F; Ferrero A; Scalzo MS; Canuto EM; Sapino A; Verdun di Cantogno L; Bruna P; Aglietta M; Di Renzo MF; Valabrega G;

Impact of secondary cytoreductive surgery on survival in patients with platinum sensitive recurrent ovarian cancer: analysis of the CALYPSO trial in Gynecologic oncology

2015
AO Ordine Mauriziano

Pujade-Lauraine E; Friedlander M; Scambia G; Ferrero A; Harter P; Heywood M; Schauer C; Vergote I; Gebski V; Hardy-Bessard A-C; Sehouli J; Woie K; Lee CK; Lord S; Grunewald T;

Angiogenesis and molecular markers in advanced epithelial ovarian cancer: a retrospective study. in Gynecologic oncology / Gynecol Oncol. 2011 Nov;123(2):301-7. doi: 10.1016/j.ygyno.2011.07.026. Epub 2011 Aug 20.

2011
AO Ordine Mauriziano

Ferrero A; Dompè D; Ravarino N; Ramella A; Fuso L; Maggiorotto F; Tripodi E; Zola P;

Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report. in Gynecologic oncology / Gynecol Oncol. 2005 Dec;99(3 Suppl 1):S187-91. doi: 10.1016/j.ygyno.2005.07.079. Epub 2005 Sep 26.

2005
AO Ordine Mauriziano

Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P;

Pretreatment serum hemoglobin level and a preliminary investigation of intratumoral microvessel density in advanced ovarian cancer. in Gynecologic oncology / Gynecol Oncol. 2004 Nov;95(2):323-9. doi: 10.1016/j.ygyno.2004.07.053.

2004
AO Ordine Mauriziano

Ferrero A; Zola P; Mazzola S; Fuso L; Sarotto I; Ravarino N; Spanu PG; Jacomuzzi ME; Carus AP; Sismondi P;